Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir + Truvada for HIV Post-Exposure Prophylaxis
NCT00594646Phase 4Completed
- Sponsor
- Fenway Health
- Start
- Feb 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Fenway Health. Started Feb 2008; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00594646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594646.